Toxic epidermal necrolysis during camrelizumab treatment for esophageal squamous cell carcinoma

作者全名："Peng, Yuan; Yu, Qian; Zhang, Xiaoyue; Zeng, Chuan; Zhou, Yan; Huang, Yusheng; Yang, Zhenzhou"

作者地址："[Peng, Yuan; Yu, Qian; Zhang, Xiaoyue; Zeng, Chuan; Zhou, Yan; Huang, Yusheng; Yang, Zhenzhou] Chongqing Med Univ, Affiliated Hosp 2, Dept Canc Ctr, Tianwen Ave 288, Chongqing 400010, Peoples R China; [Peng, Yuan] Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Resp Med, Med Ctr 2, Beijing, Peoples R China; [Peng, Yuan] Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China"

通信作者："Peng, Y (通讯作者)，Chongqing Med Univ, Affiliated Hosp 2, Dept Canc Ctr, Tianwen Ave 288, Chongqing 400010, Peoples R China."

来源：CONTACT DERMATITIS

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:000743324100001

JCR分区：Q1

影响因子：5.5

年份：2022

卷号：86

期号：5

开始页：417

结束页：419

文献类型：Editorial Material

关键词：Auto-immune antibodies; camrelizumab; case report; dermatitis; immune-related adverse events; toxic epidermal necrolysis (TEN)

摘要：　

基金机构：CSCO Oncology Research Fund [Y-2019AZQN-0444]; National Natural Science Foundation of China [81802984]; Natural Science Foundation of Chongqing [cstc2020jcyj-msxmX0208]

基金资助正文："CSCO Oncology Research Fund, Grant/Award Number: Y-2019AZQN-0444; National Natural Science Foundation of China, Grant/Award Number: 81802984; Natural Science Foundation of Chongqing, Grant/Award Number: cstc2020jcyj-msxmX0208"